Longitudinal outcomes of non-transplanted ornithine transcarbamylase deficiency in males and females: a multicentre UK natural history cohort

Orphanet Journal of Rare Diseases · Published 2026-07-28 · DOI 10.1186/s13023-026-04517-w

Free full text

Authors (27)

Berna Seker-Yilmaz, Julien Baruteau, Raphael Buttigieg, Anupam Chakrapani, Michael Champion, Catherine Davies, James Davison, Marjorie Dixon, Sherry Fang, Emma Footitt, Joanna Gribben, Stephanie Grunewald, Gemma Hack, Thomas Hartley, Hugh Lemonde, Philippa Mills, Andrew A. M. Morris, Helen Mundy, Dinusha Pandithan, Radha Ramachandran, Siyamini Sivananthan, Chern Tan, Dexter Tarr, Louise Van Dorp, Roshni Vara, Abigail Woodward, Paul Gissen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Seker-Yilmaz, B., Baruteau, J., Buttigieg, R., et al. (2026). Longitudinal outcomes of non-transplanted ornithine transcarbamylase deficiency in males and females: a multicentre UK natural history cohort. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/s13023-026-04517-w

Related articles

• The Italian Spina Bifida registry: insights from the first 1,000 patient data · Orphanet Journal of Rare Diseases · 2026 · Same journal
• Cognitive function in adult NF1 patients without other cognitive disorders: a cross-sectional study · Orphanet Journal of Rare Diseases · 2026 · Same journal
• Launching a multi-level data strategy for rare eye diseases: a methodological case study from national to European scale · Orphanet Journal of Rare Diseases · 2026 · Same journal
• Harmonizing gene nomenclature and disease classification for ADSS1 myopathy · Orphanet Journal of Rare Diseases · 2026 · Same journal
• Prevalence and cardiovascular phenotypes of dextrocardia and situs inversus among 277,396 adults: longitudinal evidence of amplified age-related blood pressure progression · Orphanet Journal of Rare Diseases · 2026 · Same journal
• Paediatric palliative approach in the era of disease modifying therapies in spinal muscular atrophy — a comprehensive landscape of French specialist physicians’ perspectives · Orphanet Journal of Rare Diseases · 2026 · Same journal
• Use of European registries to characterise the changing landscape of disease progression and treatment of spinal muscular atrophy (SMA): opportunities, pitfalls and challenges · Orphanet Journal of Rare Diseases · 2026 · Same journal
• Genetic landscape of phenylketonuria in Brazil · Orphanet Journal of Rare Diseases · 2026 · Same journal
• Clinical, pathological, and genetic characteristics of 23 DMD patients in northern China · Orphanet Journal of Rare Diseases · 2026 · Same journal
• Clinical characteristics of tumor-induced osteomalacia lesions in the neurocranium and intracranial structures · Orphanet Journal of Rare Diseases · 2026 · Same journal